Bretazenil

CAS No. 84379-13-5

Bretazenil ( Ro 16-6028 )

Catalog No. M27608 CAS No. 84379-13-5

Bretazenil is a GABAA benzodiazepine site partial agonist. Bretazenil shows an EC50 of 10 nM for recombinant α1β1γ2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 66 Get Quote
5MG 101 Get Quote
10MG 165 Get Quote
25MG 358 Get Quote
50MG 533 Get Quote
100MG 761 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Bretazenil
  • Note
    Research use only, not for human use.
  • Brief Description
    Bretazenil is a GABAA benzodiazepine site partial agonist. Bretazenil shows an EC50 of 10 nM for recombinant α1β1γ2.
  • Description
    Bretazenil is a GABAA benzodiazepine site partial agonist. Bretazenil shows an EC50 of 10 nM for recombinant α1β1γ2.(In Vitro):Bretazenil was the most potent benzodiazepine examined, exhibiting an IC50 of 6.1 nM, compared to clonazepam (7.9 nM), flunitrazepam (13.6 nM) and diazepam (91.1 nM). The rank order of potency for inhibition of [35S]TBPS binding was identical to that for inhibition of [3H]flunitrazepam binding. However, Bretazenil was less efficacious in that it produced 27% inhibition of specific [35S]TBPS binding, compared to clonazepam (34%), flunitrazepam (41%) or diazepam (49%). Bretazenil antagonized the inhibition of [35S]TBPS binding produced by 10 microM diazepam. Bretazenil was also more potent and less efficacious than diazepam in potentiating GABA-stimulated 36Cl- uptake.(In Vivo):Bretazenil, was studied in 240 rats in five age groups: age 7, 12, 18, 25 and 90 days. Motor seizures induced by metrazol (pentamethylenetetrazol, PTZ, 100 mg/kg subcutaneously (s.c.) except for 18-day-old rats which received a dose of 90 mg/kg) served as a model. Animals were pretreated with Bretazenil in doses of 0.001-0.1 mg/kg intraperitoneally 10 min before metrazol. Both types of metrazol-induced seizures, minimal (mMS, predominantly clonic with preserved righting ability) and major (MMS, generalized tonic-clonic), were suppressed by Bretazenil in a dose-dependent manner. Major seizures were always more sensitive to Bretazenil than were minimal seizures. The youngest rats exhibited maximal effects of Bretazenil against major seizures. On the other hand, this drug increased the incidence of minimal seizures in 7- and 12-day-old rats, i.e., in age groups in which this type of seizure is rare under control conditions.
  • Synonyms
    Ro 16-6028
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    84379-13-5
  • Formula Weight
    418.3
  • Molecular Formula
    C19H20BrN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    BrC1=C2C(N3[C@H](C4=C(C(OC(C)(C)C)=O)N=CN4C2=CC=C1)CCC3)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhao F, et al. [Anthraquinones from the roots of Knoxia valerianoides]. Zhongguo Zhong Yao Za Zhi. 2011 Nov;36(21):2980-6. Chinese.
molnova catalog
related products
  • 1,3,5-Trimethyl-1H-P...

    1,3,5-Trimethyl-1H-Pyrazole-4-Carboxylic Acid is a marine derived natural products found in Cinachyrella sp.

  • DEBIO 1143

    DEBIO 1143 (AT-406, DEBIO-1143, SM406, ARRY-334543, D1143) is potent, orally active Smac mimetic that antagonizes cIAP1, cIAP2 and XIAP with Ki of 66.4, 1.9 and 5.1 nM, respectively.

  • SR11237

    SR11237 is a Pan retinoid X receptor (RXR) agonist. SR11237 causes RXR/RXR homodimers to form and transactivate a reporter gene containing a RXR-response element.